As a treatment of hypercholesterolemia, simvastatin competitively binds to HMG-coenzyme A with HMGR (Maciejak et al., 2013), reducing the synthesis of cholesterol (or ergosterol in yeast). Here, HMGA1 is linked to Hypercholesterolemia.